Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | ATM | Q13315 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.43 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.43 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.39 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL28202551 | 0.88 | KMT2A (0.46) | KMT2AATMMAPTHSP90AA1MEN1 | |
| SCHEMBL6050004 | 0.85 | KMT2A (0.43) | KMT2AATMMAPTHSP90AA1MEN1 | |
| Phenol SCHEMBL27915790 | 0.84 | KMT2A (0.48) | KMT2AATMMAPTHSP90AA1MEN1 | |
| SCHEMBL28144521 | 0.83 | KMT2A (0.42) | KMT2AATMMAPTHSP90AA1MEN1 | |
| SCHEMBL12329402 | 0.83 | ACHE (0.48) | KMT2AATMMAPTHSP90AA1MEN1 | |
| SCHEMBL8168365 | 0.83 | CD44 (0.50) | KMT2AATMMAPTHSP90AA1MEN1 | |
| SCHEMBL14094866 | 0.83 | KMT2A (0.42) | KMT2AATMMAPTHSP90AA1MEN1 | |
| SCHEMBL14256812 | 0.83 | KMT2A (0.42) | KMT2AATMMAPTHSP90AA1MEN1 | |
| SCHEMBL4755413 | 0.83 | ATM (0.50) | KMT2AATMMAPTHSP90AA1MEN1 | |
| SCHEMBL9965047 | 0.83 | ALDH1A1 (0.48) | KMT2AATMMAPTHSP90AA1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030109051-A1 | Spin trap for use in biological systems | RANDOX LABORATORIES LTD (IE) | 2003-06-12 | — | — | US | claimed |
| EP-1302771-A2 | Spin trap for use in biological systems | Randox Laboratories Ltd. (GB) | 2003-04-16 | — | — | EP | claimed |
| CN-1362405-A | Nitroso compound and use of it as spin catching agent | RANDOV LAB LTD (GB) | 2002-08-07 | — | — | CN | claimed |
| US-4129740-A | Process for the preparation of para-nitroso-diphenylhydroxylamines | AKZONA INCORPORATED (US) | 1978-12-12 | — | — | US | claimed |
| EP-3544986-B1 | BRIDGED TRIARYLAMINES FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2020-12-23 | — | — | EP | disclosed |
| CN-104981460-B | Synthesis of N-heterocyclic carbenes and intermediates thereof | 圣安德鲁斯大学董事会 | 2018-01-23 | — | — | CN | disclosed |
| CN-105793236-B | Dimethylbenzoic acid compound | 伊莱利利公司 | 2017-10-10 | — | — | CN | disclosed |
| US-9765020-B2 | Dichlorophenyl-imino compounds and compositions, and methods for the treatment of mucositis | CELLIX BIO PRIVATE LIMITED (IN) | 2017-09-19 | — | — | US | disclosed |
| US-9765020-B2 | Dichlorophenyl-imino compounds and compositions, and methods for the treatment of mucositis | CELLIX BIO PRIVATE LIMITED (IN) | 2017-09-19 | — | — | US | disclosed |
| US-9738753-B2 | Programmed degradation of polymers derived from biomass | NDSU RESEARCH FOUNDATION (US) | 2017-08-22 | — | — | US | disclosed |
| US-20160362380-A1 | METHOD FOR DECARBOXYLATION OF AMINO ACIDS VIA IMINE FORMATION | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2016-12-15 | — | — | US | disclosed |
| US-20150307446-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUCOSITIS | CELLIX BIO PRIVATE LIMITED (IN) | 2015-10-29 | — | — | US | disclosed |
| US-20030109051-A1 | Spin trap for use in biological systems | RANDOX LABORATORIES LTD (IE) | 2003-06-12 | — | — | US | disclosed |
| EP-1302771-A2 | Spin trap for use in biological systems | Randox Laboratories Ltd. (GB) | 2003-04-16 | — | — | EP | disclosed |
| EP-1302771-A2 | Spin trap for use in biological systems | Randox Laboratories Ltd. (GB) | 2003-04-16 | — | — | EP | disclosed |
| CN-1362405-A | Nitroso compound and use of it as spin catching agent | RANDOV LAB LTD (GB) | 2002-08-07 | — | — | CN | disclosed |
| EP-0009267-B1 | PROCESS FOR THE PREPARATION OF P-NITROSO-DIPHENYLHYDROXYLAMINES | AKZO N.V. (NL) | 1981-11-25 | — | — | EP | disclosed |
| US-4242523-A | Process for the preparation of para-nitroso-diphenyl-hydroxylamines | AKZONA INCORPORATED (US) | 1980-12-30 | — | — | US | disclosed |
| EP-0009267-A1 | Process for the preparation of p-nitroso-diphenylhydroxylamines | AKZO N.V. (NL) | 1980-04-02 | — | — | EP | disclosed |
| US-4129740-A | Process for the preparation of para-nitroso-diphenylhydroxylamines | AKZONA INCORPORATED (US) | 1978-12-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160362380-A1 | METHOD FOR DECARBOXYLATION OF AMINO ACIDS VIA IMINE FORMATION | BCAT2, AADAT, BCAT1 | KMT2A 1596/4885ATM 80/4885MAPT 942/4885 |
| US-20150307446-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUCOSITIS | MUC1, SI, ALPI | KMT2A 4850/4885ATM 2970/4885MAPT 2326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.